Home
>
National Drug Code (NDC)
>
Protonix
Protonix - 0008-0841-17 - (PANTOPRAZOLE SODIUM)
Drug Information of Protonix
| Product NDC: | 0008-0841 |
| Proprietary Name: | Protonix |
| Non Proprietary Name: | PANTOPRAZOLE SODIUM |
| Active Ingredient(s): | 40 mg/1 & nbsp; PANTOPRAZOLE SODIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Protonix
| Product NDC: | 0008-0841 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020987 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000501 |
Package Information of Protonix
| Package NDC: | 0008-0841-17 |
| Package Description: | 5 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0008-0841-17) |
NDC Information of Protonix
| NDC Code | 0008-0841-17 |
| Proprietary Name | Protonix |
| Package Description | 5 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0008-0841-17) |
| Product NDC | 0008-0841 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PANTOPRAZOLE SODIUM |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20000501 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | PANTOPRAZOLE SODIUM |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
